Clinical Trial Update: The Efficacy and Safety of Fruquintinib Plus Chemotherapy as Second-line Treatment in Metastatic Colorectal Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating fruquintinib combined with chemotherapy as second-line treatment for metastatic colorectal cancer, focusing on efficacy…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Fruquintinib (fruquintinib)

Snippet

Sponsor: Fudan University | Conditions: Metastatic Colorectal Cancer | Phase 2 | Status: UNKNOWN